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ABSTRACT 
 
Among marine animals, reef’s invertebrates are the most prolific producers of secondary metabolites and 
have become sources of great interest to natural product chemistry, since they provide a large proportion of 
bioactive compounds with different biological activities. Supply’s problem has hampered the investigation 
of secondary metabolites from marine invertebrates, and  many highly active compounds produced 
contribute to<10
-6 
% of the body-wet weight. Providing sufficient amounts of these biologically active 
substances, hence, may be a difficult task. In addition, it has often proven extremely difficult, and some 
cases impossible, to provide from invertebrates sufficient amounts of many of these substances due to 
limited amounts found in the producing organism, or to limited quantity of the organism itself, or to 
geographic, seasonal or sexual variations in the amounts and in the nature of produced secondary 
metabolites. There has an increasing concerns regarding the collecting reef’s organisms for the discovery 
and development of pharmaceuticals since it has been perceived variously as sustaining and threatening 
conservation. There is an urgent need to take into account the bioethical considerations in anticipating the 
potential consequences of these activities and proposing management options for sustainable use of reef’s 
invertebrates as the sources of bioactive compounds. 
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INTRODUCTION 
 
At the World Summit on Sustainable 
Development held at  Rio de Janeiro, Brazil in 
1992, five major areas were outlined for 
progress in achieving a sustainable future for 
humanity, namely water and sanitation, 
energy, health, agricultural productivity, and 
biodiversity and ecosystem management. 
Hence, it has become clear that biodiversity 
has become one of the cornerstones of 
sustainable development and has been defined 
as the sum of genetic and phenotypic 
differences existing in living organisms at the 
molecular, individual, population, and 
ecosystem levels. The increased emphasis on 
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biodiversity is the result of, on the one hand, 
an increased demand, driven by factors as 
diverse as plant breeding, drug development, 
and ecosystem services, and, on the other 
hand, by decreasing supplies, caused by 
overpopulation and globalization and the 
ensuing habitat destruction and cultural 
homogenization (Gepts, 2004). 
Coral reefs are some of the most 
productive ecosystems on earth, and are 
certainly the most productive and species-rich 
environments in the oceans. Coral reefs 
provide critical protection to coastlines from 
storm damage, erosion and flooding by 
reducing wave action. Coral reefs are crucial 
sources of income and resources through their 
role in tourism, fisheries, and building 
materials. Despite the apparent value of coral 
reefs to humans, most of the reefs around the 
world are threatened or already been destroyed 
by human activities. The 1998 Reefs at Risk 
report (Bryant et al. 1998) reported that 58% 
of the world’s reefs are potentially threatened 
by human activities.  
The oceans are the source of a large 
group of structurally unique natural products 
that are mainly accumulated in invertebrates 
that are common to coral reef ecosystems, 
such as sponges, tunicates, bryozoans, soft 
corals and molluscs. Several of these 
secondary metabolites showed pronounced 
pharmacological activities and are interesting 
candidates for new drugs and coral reef 
ecosystem has been one of the main sources 
for the search of bioactive compounds 
(Radjasa, 2003). 
Serious obstacle to the ultimate 
development of most marine natural products 
that are currently undergoing evaluation and 
trials is the problem of supply due their low 
concentrations (Munro et al. 1999). The 
concentrations of many highly active 
compounds in marine invertebrates are often 
minute, sometimes accounting for less than 10
-
6 
% of the wet weight (Procksch et al. 2002). 
In addition, it has often proven 
extremely difficult, and some cases 
impossible, to provide from invertebrates 
sufficient amounts of many of these substances 
due to limited amounts found in the producing 
organism, or to limited quantity of the 
organism itself, or to geographic, seasonal or 
sexual variations in the amounts and in the 
nature of produced secondary metabolites 
(Kelecom, 2002).  
The urgent need to protect and study 
tropical biodiversity is widely known. 
Scientists from all over the world have 
identified the need to intensify field studies in 
tropical biodiversity and to make its protection 
a high priority for this century (Raven, 2000). 
Regarding the use of reef’s invertebrates 
as sources of bioactive compounds, it has been 
primarily concerned with protection of the 
environment and sustainability. The ecological 
ethics need to be taken into account, especially 
in the light of the importance of coral reefs for 
human population in tropical coastal 
communities. Thus, considering bioethical 
persperctives and finding alternative solutions 
to the problem supply for bioactive 
compounds mainly produced by reef’s 
invertebrates should be given high priority.  
 
 
THE SEARCH FOR BIOACTIVE 
COMPOUNDS FROM REEF’S 
INVERTEBRATES 
 
Marine organisms including those from coral 
reef ecosystems have become sources of great 
interest to natural product chemistry, since 
they provide a large proportion of bioactive 
metabolites with different biological activities 
(Faulkner 2000). In particular, marine 
invertebrates with high species diversity in the 
tropical coral reefs are often rich in secondary 
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metabolites and are preferential targets in the 
search for bioactive natural products 
(Sammarco and Coll 1992). 
Many marine species have been 
collected in the search for novel bioactive 
compounds and for developing pharmaceutical 
drugs (Hooper et al. 1998; Quinn et al. 2002). 
The collections tend, however, to focus on 
organisms containing chemicals, known as 
secondary metabolites that primarily serve 
ecological functions in competition for space 
and in protection from predation, fouling, and 
ultraviolet light (Harper et al. 2001), as well 
from bacterial infections (Correa, 1997; 
Rohwer et al. 2002)  To date, the majority of 
novel compounds have been secondary 
metabolites from soft-bodied, sessile 
invertebrates, such as Porifera (sponges); 
Cnidaria (jellyfish, corals, sea anemones); and 
Urochordata (ascidians). 
Marine species have become of 
increasing interest to bioprospectors for 
Western medicinals. Over 14 000 new 
chemical entities have been identified from 
marine sources, and at least 300 patents have 
been issued on marine natural products (Hunt 
and Vincent, 2006).  
A set of new generation of marine-
derived pharmaceuticals are expected to enter 
the market, including a chronic pain treatment, 
Prialt (ziconitide)—which is based on a 
peptide isolated from the cone shell, Conus 
magnus (Olivera, 2000)—and the anticancer 
drug Yondelis (ecteinascidin 743), from the 
ascidian Ecteinascidia turbinata (Rinehart et 
al. 1990). 
 
 
BIOETHICAL CONSIDERATIONS 
 
In the context of marine biodiversity, bioethics 
may be concerned with the ethical questions 
and evaluations of animal, plants and 
microorganisms that being used for human 
needs.   
Temperate marine ecosystems are some 
of the most productive and diverse of all 
ecosystems. Over the past century the 
resources contained within these communities 
have been subjected to gross mismanagement 
(Suchanek, 1994).  
The most significant threat regarding the 
development of pharmaceutical from reef’s 
invertebrates is the problem of supply. 
Providing sufficient amounts of these 
biologically active substances, hence, may be a 
difficult task. Limited amounts and low yields 
of bioactive compounds produced (Table 1), 
further complicate the study of secondary 
metabolites of aquatic organisms (Radjasa et 
al. 2007a). In addition, as a result of the 
enormous marine natural product development 
of recent decades and their applications, many 
unforeseen problems of an ethical nature have 
also arisen. 
 
Table 1. Low yields of bioactive compounds from reef’s invertebrates 
No Compound Invertebrate Yield/wet weight 
(gr/metric ton) 
1 Anticancer ET 743 Tunicate 
Ecteinascidia turbinata 
1 
2 Anticancer  
Halicondrin 
Sponge 
Lissodendroryx  sp. 
 
0.3 
3 
 
Anti-inflamatory Pseudopterosins Soft coral 
Pseudopterogorgia elisabethae 
 
1 
Sources: (Mendola, 2000; Hart et al. 2000 ; Mayer et al. 1998) 
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There is a pressing need, now more than 
ever, to call worldwide attentions to the 
widening gap between the exploitation of 
marine organisms and its ethical implications. 
The rapid development of marine natural 
products, in particular those related to the use 
of reef’s invertebrates as the source of 
bioactive compounds needs the ethical 
implications that must develop alongside. 
We recognize the dependence of marine 
biotas on intact, functioning ecosystems, and 
the essential services that ecosystems provide. 
There is an urgent action to reduce 
environmental damage by humans that reduces 
reef’s biodiversity. Whereas these 
invertebrates provide medicinal metabolites, 
this group of soft-bodied organism is in grave 
danger from over exploitation by humans. 
Reef’s often cannot protect themselves from 
humans, so without our help they cannot 
survive. Therefore, it is important to make the 
protection of reef’s invertebrates and their 
habitat a top priority.  
Bioethical wisdom that combines 
ecological knowledge with a sense of moral 
responsibility for a livable world is what is 
needed at the moment. What we must do for 
the health and survival of the next several 
generations in a recovering biosphere is what 
we ought to do for the generations in the far 
future.  
Impacts from stresses on coastal marine 
communities are manifested at the individual 
species level, but magnify in effect throughout 
the entire ecosystem because of complex inter-
connected relationships between species at 
different trophic levels, including interactions 
such as predation, competition and mutualism. 
In addition, we should be conservative about 
protecting systems even before we understand 
the processes fully (Suchanek, 1994) 
 
 
 
REEF’S  INVERTEBRATE 
ASSOCIATED MICROORGANISMS 
AS ALTERNATIVE SOURCE OF 
BIOACTIVE COMPOUNDS 
 
Globally, since 1995, there are signals of 
decreased interest in the search of new 
metabolites from traditional sources such as 
macroalgae, molluscs, tunicates and 
octocorals, and the number of annual reports 
on marine sponges stabilized. On the contrary, 
the metabolites from microorganisms is a 
rapidly growing field, due, at least in part, to 
the suspicion that a number of metabolites 
obtained from algae and invertebrates may be 
produced by associated microorganisms 
(Kelecom, 2002). 
It is a widely observed phenomenon that 
microbial cells attach firmly to almost any 
surface submerged in marine environments, 
grow, reproduce, and produce extracellular 
polymers that provide structure to the 
assemblage termed as biofilm (Kioerboe et al. 
2003). In addition, surfaces of many marine 
invertebrates providing a nutrient rich habitat 
for heterotrophic bacteria that leading to the 
formation of biofilm-forming microbial 
communities.  
It has been estimated that less than 2% 
of microbial flora have been successfully 
isolated from marine environment as pure 
cultures. It is expected that still quite a few 
parts of unexplored culturable invertebrate-
associated microorganisms exists in the reef 
environments. Thus, such information might 
be desirable, as some of these bacteria may 
serve beneficial purposes as the source of 
secondary metabolites including marine 
natural products (Radjasa and Sabdono, 2003; 
Radjasa et al. 2007a, 2007b). 
Understanding of marine invertebrate-
microbial associations is a fundamental step in 
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studying biologically potential active, possible 
medicinal compound from associated 
microorganisms. In particular, from 
sustainability point of view, isolating 
bioactive-producing bacteria is obviously 
offers a much better approach than cultivating 
and harvest invertebrates, which are in most 
cases extremely difficult. 
It has been suggested that natural 
products from marine invertebrates have 
stricking similarities to metabolites of their 
associated microorganisms (Proksch et al, 
2002; Thiel and Imhoff, 2003). Thus, it is 
important to highlight the possible role of 
bacteria associated with marine invertebrates 
as an alternative of biologically active 
substances. 
Studies regarding screening on 
secondary metabolites-producing invertebrate-
associated bacteria are important for 
understanding principal processes inhibitory 
interaction among invertebrate-associated 
bacteria as well as their biotechnological 
potentials. In this context, it is of importance 
to assess the application of sustainable 
approach on the screening of invertebrate-
associated microbial populations with specific 
consideration of the secondary metabolites-
producing part which has been up to now 
strongly neglected in comparison to the 
invertebrate parts (Radjasa and Sabdono, 
2003; Radjasa et al. 2007a). The results will 
further influence isolation approaches and will 
show alternative choice in order to obtain 
representative reef’s active metabolites coral 
reef ecosystems without endangering this 
precious environment. 
 
 
CONCLUDING REMARKS 
 
One of the main conservation concerns about 
the exploitation of reef’s invertebrates in 
bioprospecting for the search of bioactive 
compounds is possible overcollection of target 
organisms. Due to the low yields of particular 
active metabolites from reef’s invertebrates, it 
is very urgent to consider the bioethical 
considerations that will guide in the 
sustainable use of these important groups 
within coral reefs.  
Studies regarding the possible roles of 
marine microorganisms associated reef’s 
invertebrates should be highlighted as  
alternative sources of bioactive compounds 
that will protect the invertebrates from 
unsustainable exploitation. 
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